Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
EBS
Emergent BioSolutions Inc.
NYSE · Pharmaceutical Preparations
Last close
$6.33
· 2026-10-02
ABOUT
Exchange
NYSE
Sector
Healthcare
Industry
Pharmaceutical Preparations
Market cap
$338.40M
RECENT INSIDER TRADES
2026-10-07
· DeGolyer Donald W
(Director)
· SELL
2026-10-05
· Williams Paul Anthony
(SVP, Products Business)
· SELL
2026-07-02
· Williams Paul Anthony
(SVP, Products Business)
· SELL
2026-06-10
· LINDAHL RICHARD S
(EVP, Chief Financial Officer)
· OTHER
2026-06-10
· Williams Paul Anthony
(SVP, Products Business)
· OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders
207
Shares held
52,280,774
Value
$420.45M
Percent of shares outstanding
101.96%
As of quarter end
2026-06-30
RECENT CONGRESSIONAL TRADES
2024-12-11
· Hon. Steve Cohen · SELL
· $1,001 - $15,000
RECENT NEWS
Why is Emergent Biosolutions stock surging today?
EBS: INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Emergent BioSolutions Inc. - EBS
Emergent BioSolutions to hold ribbon cutting for Canton manufacturing facility restart
Emergent BioSolutions restructuring includes 90 job cuts
Emergent BioSolutions presents at H.C. Wainwright conference
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Emergent BioSolutions Inc. (EBS) · Stock Price, Insider Trades, Congress Trades · CatalystPit